TrialClinical and translational science2025

Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers.

Anjli Kukreja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.